Community Interest in Vision Screening Technology

NCT04980430 | Completed DMC

• 1 other identifier: Study-20-00358
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

Virtual reality (VR) is a relatively new, emerging field within healthcare. Studies have analyzed public perceptions of virtual reality in healthcare using social media, but few have actually demonstrated and educated these modalities to communities. Because vision care can be costly and inaccessible, especially in communities with few physicians, this study aims to evaluate whether communities would be open to new technology. For example, it has been determined that 80% of vision loss is preventable with adequate screening technology, a key factor in ameliorating the economic and emotional burden of eye disease. Therefore, through demonstrations and educational presentations by medical students, gaps in understanding perceptions, willingness to adopt, and general demographics of those seeking better eye care will be understood.

Conditions

Ophthalmology; Vision Screening

Keywords

Ophthalmology; Virtual Reality; Community; Vision

Outcome Measures

Primary Outcomes (1)

• Virtual Reality Assessment

  Participant assessment of VR technology. Items scored on a likert-scale format from 1 (strongly disagree) to 5 (strongly agree). Full scale from 13 to 65, with higher score indicating more favorable responses.

  Day 1

Secondary Outcomes (1)

• Demographics Assessment

  Day 1

Study Arms (1)

Primary Care and Ophthalmology clinic patients

Participants will be recruited from primary care and ophthalmology clinics in New York City

Device: Virtual Reality

Interventions

Virtual Reality DEVICE

Virtual Reality Demonstration

Primary Care and Ophthalmology clinic patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Subjects will be recruited from primary care and ophthalmology clinics in New York City. Participants can schedule a time to participate in the study on their own or may be recruited by a student at their appointment.

You may qualify if:

• Males and females of any race
• At least 18 years of age
• Participants must be able to understand and provide verbal and written consent. Only participants who undergo the demonstration of the technology and consent to the study after full explanation will be included in research.

You may not qualify if:

• \- People who have undergone intraocular surgery less than six months ago, and potential contraindication for visual field test that include anxiety disorder, pregnancy, seizure disorder, cardiac pacemaker or another implantable device, severe vertigo or balance.

Sponsors & Collaborators

• Icahn School of Medicine at Mount Sinai: lead

Study Sites (1)

Mount Sinai Ophthalmology Faculty Practice Associates

New York, New York, 10029, United States

Location

Study Officials

• James Chelnis, MD

  Icahn School of Medicine at Mount Sinai

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Clinical Professor

Study Record Dates

• First Submitted: July 18, 2021
• First Posted: July 28, 2021
• Study Start: October 1, 2020
• Primary Completion: October 20, 2022
• Study Completion: October 20, 2022
• Last Updated: August 28, 2024

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP
• Time Frame: Immediately following publication. No end date.
• Access Criteria: Investigators whose proposed use of the data has been approved by an independent review committee ('learned intermediary') identified for this purpose. Any purpose. Data available on specific request and will be shared securely as CSV

Locations

US (1)